Results 91 to 100 of about 3,331 (189)
Drospirenone-containing oral contraceptives and risk of venous thromboembolism
Combined oral contraceptives (COCs) are widely used by women to prevent unwanted pregnancies. The fourth generation of COCs, containing the progestin drospirenone, came on the market in 2000.
Larivee, Natasha
core
Objective. To verify the effects of a pill containing drospirenone on the surrogate markers of arterial function and to evaluate the possible improvements induced by the addition of l-arginine. Design. A prospective, placebo controlled, randomised, pilot
F. Facchinetti +22 more
core +1 more source
Introduction. Androgen-dependent dermopathy, as well as premenstrual syndrome of varying severity in young women, can cause emotional depression, difficulties in social adaptation and even depressive disorders.
A.R.Khachaturian +2 more
doaj
COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
Polycystic Ovary Syndrome (PCOS) presents actual problem in gynecology. In present time discussions on PCOS classification and diagnostics criteria are not completed.
M. A. Gevorkyan +2 more
doaj
International Congress on the Biology of Fish (ICBF2014), 3-7 August, 2014 Heriot-Watt University, Edinburgh.-- 2 pagesThe presence of progestagens in aquatic systems via waste-water effluents has significantly increased in the last decade.
Medina, Paula +4 more
core
Quality of life of women as the criterion of effectiveness of premenstrual syndrome therapy
Quality of life is one of the criteria for therapy effectiveness assessment. The study’s aim was to assess the indicators of quality of life of patients with premenstrual syndrome (PMS) of moderate and severe gravity before and after combined therapy via
A V Ledina
doaj
Distinct immunomodulatory effects of synthetic progestins compared with natural progesterone in human immune cells. [PDF]
Patel AJ +4 more
europepmc +1 more source
Effects of estetrol/drospirenone vs drospirenone-only on thrombin generation in women with polycystic ovary syndrome: a randomized, double-blind, controlled trial. [PDF]
Chantrapanichkul P +9 more
europepmc +1 more source
Estetrol/drospirenone for combined oral contraception: a systematic review of efficacy, cycle control, and safety. [PDF]
Sánchez-Prieto M +6 more
europepmc +1 more source

